Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?

[1]  M. Ragonese,et al.  Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life , 2022, Endocrine.

[2]  S. Volpato,et al.  Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study , 2021, BMC Geriatrics.

[3]  A. Pontecorvi,et al.  Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: Clinical effectiveness and predictors of response. , 2020, European journal of endocrinology.

[4]  S. Samson,et al.  A Pituitary Society update to acromegaly management guidelines , 2020, Pituitary.

[5]  P. Chanson,et al.  Multidisciplinary management of acromegaly: A consensus , 2020, Reviews in Endocrine and Metabolic Disorders.

[6]  M. Fleseriu.  Faculty Opinions recommendation of Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[7]  M. Fleseriu,et al.  Acromegaly in the elderly patients , 2020, Endocrine.

[8]  A. Pontecorvi,et al.  Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study. , 2019, The Journal of clinical endocrinology and metabolism.

[9]  M. Losa,et al.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series , 2019, Endocrine.

[10]  S. Cannavò,et al.  Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity , 2019, Pituitary.

[11]  P. Chanson,et al.  Acromegaly , 2019, Nature Reviews Disease Primers.

[12]  M. Marazuela,et al.  Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them? , 2019, Front. Endocrinol..

[13]  A. Pontecorvi,et al.  Acromegaly can be cured by first-line pasireotide treatment? , 2019, Endocrine.

[14]  M. Fleseriu,et al.  Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. , 2018, Endocrine reviews.

[15]  A. Giampietro,et al.  Somatotropic Axis in Human Aging , 2019, Encyclopedia of Endocrine Diseases.

[16]  Y. Hayashi,et al.  Transsphenoidal Surgery for Elderly Patients with Acromegaly and Its Outcomes: Comparison with Younger Patients. , 2018, World neurosurgery.

[17]  M. Nakhjavani,et al.  Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients. , 2018, World neurosurgery.

[18]  P. Chanson,et al.  A Consensus Statement on acromegaly therapeutic outcomes , 2018, Nature Reviews Endocrinology.

[19]  B. Emir,et al.  USE OF ELECTRONIC HEALTH RECORDS TO CHARACTERIZE A RARE DISEASE IN THE U.S.: TREATMENT, COMORBIDITIES, AND FOLLOW-UP TRENDS AMONG PATIENTS WITH A CONFIRMED DIAGNOSIS OF ACROMEGALY. , 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[20]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[21]  P. Chanson,et al.  Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database , 2017, Endocrine-related cancer.

[22]  A. Cañete,et al.  Acromegalic arthropathy in various stages of the disease: an MRI study. , 2017, European journal of endocrinology.

[23]  P. Chanson,et al.  Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. , 2017, European journal of endocrinology.

[24]  H. Sørensen,et al.  Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. , 2016, European journal of endocrinology.

[25]  G. Mazziotti,et al.  Acromegalic osteopathy , 2016, Pituitary.

[26]  A. Mamelak,et al.  A structural and functional acromegaly classification. , 2015, The Journal of clinical endocrinology and metabolism.

[27]  E. Laws,et al.  Acromegaly: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[28]  B. Wolffenbuttel,et al.  Prevalence of diabetes mellitus in patients with acromegaly , 2014, Endocrine connections.

[29]  P. Chanson,et al.  Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients , 2014, Pituitary.

[30]  G. Maira,et al.  Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review , 2013, Pituitary.

[31]  A. Barkan,et al.  Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas. , 2013, The Journal of clinical endocrinology and metabolism.

[32]  S. Gultekin,et al.  Factors Associated with Biochemical Remission after Microscopic Transsphenoidal Surgery for Acromegaly , 2013, Journal of Neurological Surgery—Part B.

[33]  M. Farias,et al.  Functional evaluation of the joints in acromegalic patients and associated factors , 2013, Clinical Rheumatology.

[34]  S. Cannavò,et al.  Predictors of morbidity and mortality in acromegaly: an Italian survey. , 2012, European journal of endocrinology.

[35]  P. Chanson,et al.  Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. , 2011, European journal of endocrinology.

[36]  G. Vargas,et al.  Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism , 2011, Pituitary.

[37]  F. Greenway,et al.  An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .

[38]  B. Gerbert,et al.  Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register , 2009, Clinical endocrinology.

[39]  J. Romijn,et al.  Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease. , 2009, The Journal of clinical endocrinology and metabolism.

[40]  谷本 啓爾.  The influence of age on the GH-IGF1 axis in patients with acromegaly , 2009 .

[41]  K. Sugiyama,et al.  Treatment of elderly acromegalics. , 2008, Endocrine journal.

[42]  A. Pfeiffer,et al.  Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. , 2008, The Journal of clinical endocrinology and metabolism.

[43]  G. Vitale,et al.  A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients , 2007, Journal of endocrinological investigation.

[44]  V. Esposito,et al.  Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. , 2005, European journal of endocrinology.

[45]  P. Marzullo,et al.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management. , 2004, Endocrine reviews.

[46]  P. Chanson,et al.  Diagnosis and treatment of acromegaly complications , 2003, Journal of endocrinological investigation.

[47]  Matteo Bartolomeo,et al.  The Italian survey , 2003 .

[48]  H. Lochs,et al.  Diabetes‐Häufigkeit bei Akromegalie und Cushing‐Syndrom , 2000 .

[49]  H. Lochs,et al.  [Prevalence of diabetes in acromegaly and Cushing syndrome]. , 2000, Acta medica Austriaca.

[50]  M. Ambrosio,et al.  Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. , 1997, The Journal of clinical endocrinology and metabolism.

[51]  D. Lüdecke,et al.  Pituitary surgery in elderly patients with acromegaly. , 1995, Neurosurgery.

[52]  J. Nabarro.  ACROMEGALY , 1987, Springer US.

[53]  K. Johnson.  An Update. , 1984, Journal of food protection.